CAPTRUST FINANCIAL ADVISORS - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2023$14,042
-6.4%
10,102
+336.9%
0.00%
Q2 2022$15,000
+1400.0%
2,312
+1156.5%
0.00%
Q1 2022$1,000184
+84.0%
0.00%
Q4 2021$0
-100.0%
100
-81.8%
0.00%
Q3 2021$7,000
+75.0%
550
+227.4%
0.00%
Q2 2021$4,0000.0%168
+5.7%
0.00%
Q1 2021$4,000
-66.7%
159
-64.7%
0.00%
Q4 2020$12,000
-25.0%
4500.0%0.00%
Q3 2020$16,000
-42.9%
450
-18.2%
0.00%
Q2 2020$28,0005500.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders